Duijvelaar, Erik http://orcid.org/0000-0002-5547-5578
Gisby, Jack http://orcid.org/0000-0003-0511-8123
Peters, James E. http://orcid.org/0000-0002-9415-3440
Bogaard, Harm Jan http://orcid.org/0000-0001-5371-0346
Aman, Jurjan http://orcid.org/0000-0001-6211-1791
Funding for this research was provided by:
ZonMw (10430 01 201 0007, 10430 01 201 0007, 10430 01 201 0007)
Innovative Medicines Initiative (101005142, 101005142, 101005142)
Article History
Received: 28 April 2023
Accepted: 11 January 2024
First Online: 25 January 2024
Competing interests
: J.A. is a co-inventor of a patent (WO2012150857A1, 2011) covering protection against endothelial barrier dysfunction through inhibition of the tyrosine kinase Abl-related gene (Arg). All other authors have no competing interests to declare.